ETF Holdings Breakdown of MXCT

MXCT institutional holdings

The adjusted close for MXCT on 2025-11-11 was 1.55

The following institutional investment holdings of MXCT have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-11	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	68,761	USD 106,580 5.2%	1.55
2025-11-11	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	68,761	USD 106,580 5.2%	1.55
Total =		137,522	USD 213,160

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with MXCT

Two Sigma Advisers LP Purchases New Stake in MaxCyte, Inc. (NASDAQ:MXCT)

Two Sigma Advisers LP acquired a new position in shares of MaxCyte, Inc. (NASDAQ:MXCT – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 17,800 shares of the company’s stock, valued at approximately $74,000. Several other institutional investors and hedge funds […] - 2025-06-09 04:28:56

MaxCyte, Inc. (NASDAQ:MXCT) Stock Position Decreased by Nuveen Asset Management LLC

Nuveen Asset Management LLC cut its stake in shares of MaxCyte, Inc. (NASDAQ:MXCT – Free Report) by 27.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 268,541 shares of the company’s stock after selling 102,020 shares during the quarter. […] - 2025-06-05 04:55:11

ProShare Advisors LLC Acquires 8,481 Shares of MaxCyte, Inc. (NASDAQ:MXCT)

ProShare Advisors LLC lifted its holdings in shares of MaxCyte, Inc. (NASDAQ:MXCT – Free Report) by 32.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,462 shares of the company’s stock after purchasing an additional 8,481 shares during the quarter. ProShare Advisors LLC’s holdings […] - 2025-06-03 05:32:56

Lazard Asset Management LLC Lowers Stock Holdings in MaxCyte, Inc. (NASDAQ:MXCT)

Lazard Asset Management LLC decreased its holdings in MaxCyte, Inc. (NASDAQ:MXCT – Free Report) by 54.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 163,495 shares of the company’s stock after selling 197,955 shares during the quarter. Lazard Asset Management LLC’s holdings […] - 2025-05-21 05:39:05

Dimensional Fund Advisors LP Acquires 191,088 Shares of MaxCyte, Inc. (NASDAQ:MXCT)

Dimensional Fund Advisors LP increased its holdings in shares of MaxCyte, Inc. (NASDAQ:MXCT – Free Report) by 15.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,429,071 shares of the company’s stock after buying an additional 191,088 shares during the […] - 2025-05-12 04:50:50

Marshall Wace LLP Has $1.05 Million Stock Holdings in MaxCyte, Inc. (NASDAQ:MXCT)

Marshall Wace LLP boosted its stake in shares of MaxCyte, Inc. (NASDAQ:MXCT – Free Report) by 13.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 252,333 shares of the company’s stock after buying an additional 29,739 shares during the period. Marshall Wace LLP owned approximately 0.24% […] - 2025-04-30 04:59:04

MaxCyte, Inc. (NASDAQ:MXCT) Shares Acquired by Blair William & Co. IL

Blair William & Co. IL boosted its holdings in MaxCyte, Inc. (NASDAQ:MXCT – Free Report) by 3.6% during the 4th quarter, Holdings Channel reports. The fund owned 282,859 shares of the company’s stock after acquiring an additional 9,900 shares during the quarter. Blair William & Co. IL’s holdings in MaxCyte were worth $1,177,000 as of […] - 2025-04-03 06:09:14

Chevy Chase Trust Holdings LLC Has $5.57 Million Stake in MaxCyte, Inc. (NASDAQ:MXCT)

Chevy Chase Trust Holdings LLC lifted its position in shares of MaxCyte, Inc. (NASDAQ:MXCT – Free Report) by 0.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,339,829 shares of the company’s stock after buying an additional 7,781 shares […] - 2025-02-18 06:44:58

Back to Listing

Disclaimer